Donald E. Bobo Jr. - 25 Feb 2026 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP,Strategy/Corp Development
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
25 Feb 2026
Net transactions value
-$2,012,076
Form type
4
Filing time
26 Feb 2026, 19:33:53 UTC
Previous filing
06 Jan 2026
Next filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BOBO DONALD E JR CVP,Strategy/Corp Development ONE EDWARDS WAY, IRVINE Linda J. Park, Attorney-in-Fact 26 Feb 2026 0001196661

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Sale $2,012,076 -24,000 -53% $83.84 21,266 25 Feb 2026 Direct F1, F2
holding EW Common Stock 38,901 25 Feb 2026 401(k) F3
holding EW Common Stock 121,756 25 Feb 2026 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $83.66 to $83.96. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F2 Total reflects the correction of 13,396 shares held indirectly by the Reporting Person's trust, which were previously reported as directly held.
F3 Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.